Replies to post #192 on Tyme Technologies Inc. (TYME)

[shark44]

catalyst 2019.....
SM-88
Pancreatic cancer
Phase 2
09/29/2019
Phase 2 presentation at ESMO September 29, 2019. 12:00 PM CET.

SM-88
Prostate cancer
Phase 2
09/30/2019
Phase 2 presentation at ESMO September 30, 2019. 12:00 PM CET

If the stock moves before Sept 29th, we know that we have a big TYME winner.
GLTA